Browse by People

Perreault, Leigh, Davies, Melanie, Frias, Juan P, Laursen, Peter Norkjaer, Lingvay, Ildiko, Machineni, Sriram, Varbo, Anette, Wilding, John PH ORCID: 0000-0003-2839-8404, Wallenstein, Signe Olrik Rytter and le Roux, Carel W (2022) Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program. DIABETES CARE, 45 (10). pp. 2396-2405.

Collapse authors list.
Wilding, John PH ORCID: 0000-0003-2839-8404, Batterham, Rachel L, Calanna, Salvatore, Davies, Melanie, Van Gaal, Luc F, Lingvay, Ildiko, McGowan, Barbara M, Rosenstock, Julio, Tran, Marie TD, Wadden, Thomas A et al (show 4 more authors) , Wharton, Sean, Yokote, Koutaro, Zeuthen, Niels and Kushner, Robert F (2021) Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEW ENGLAND JOURNAL OF MEDICINE, 384 (11). pp. 989-1002.

Collapse authors list.
Kushner, Robert F, Calanna, Salvatore, Davies, Melanie, Dicker, Dror, Garvey, W Timothy, Goldman, Bryan, Lingvay, Ildiko, Thomsen, Mette, Wadden, Thomas A, Wharton, Sean et al (show 2 more authors) , Wilding, John PH ORCID: 0000-0003-2839-8404 and Rubino, Domenica (2020) Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. OBESITY, 28 (6). pp. 1050-1061.

Collapse authors list.
Wilding, John PH ORCID: 0000-0003-2839-8404, Batterham, Rachel L, Davies, Melanie, Van Gaal, Luc F, Kandler, Kristian, Konakli, Katerina, Lingvay, Ildiko, McGowan, Barbara M, Oral, Tugce Kalayci, Rosenstock, Julio et al (show 4 more authors) , Wadden, Thomas A, Wharton, Sean, Yokote, Koutaro and Kushner, Robert F (2022) Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. DIABETES OBESITY & METABOLISM, 24 (8). pp. 1553-1564.